N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose
about
Increased urinary excretion of free N-acetylneuraminic acid in thirteen patients with Salla diseaseA convenient method for the isolation of 3'-sialyllactose from normal human urineBinding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobinGuillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a.The human milk metabolome reveals diverse oligosaccharide profiles.Properties of recombinant human cytosolic sialidase HsNEU2. The enzyme hydrolyzes monomerically dispersed GM1 ganglioside molecules.Molecular characterization of membrane type and ganglioside-specific sialidase (Neu3) expressed in E. coli.The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites.Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclassMonoclonal antibody against a lactose epitope of glycosphingolipids binds to melanoma tumour cells.Characterization and partial purification of beta-N-acetylgalactosaminyltransferase from urine of Sd(a+) individuals.Properties of human liver lysosomal sialidase.Inhibition of Helicobacter pylori adhesion to human gastric mucus by a high-molecular-weight constituent of cranberry juice.Treatment of Helicobacter pylori infection using a novel antiadhesion compound (3'sialyllactose sodium salt). A double blind, placebo-controlled clinical study.Identification of long chain dicarboxylic acids in the serum of two patients with Reye's syndromeThe architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies
P921
Q28328540-79CCCCB2-5451-49EC-AD5E-AD2C778DC835Q28331023-2A0C800F-95A6-4983-B170-0FAB316A5FB4Q28615765-59307E4C-5BDC-4CDF-885D-AC94829D3F64Q31874413-FC487979-CE6D-482A-8AC8-18FB035257A3Q33851068-E7FCF593-DE41-4A11-AAA8-E1BA592A3431Q34276292-89E3E993-B63B-4AD8-B3A4-A0C5AA4EF4FAQ34324768-EE8F6C0F-3A5D-4DF7-A2BB-38AEBE404B2FQ36894391-929C4388-4B52-4823-8CEF-724A6737239FQ37421977-46AE0672-361D-41B5-9A88-EA3A6C2582F6Q38315720-16BEFF10-486B-4EF9-9DA4-B9A9942E6516Q42209205-1F16F7DB-DF47-42F2-AD0D-F116BD7E9B68Q42222518-C49A347C-6836-4D43-9C04-58AF1381B626Q44023784-193E5BD8-50B5-4FCE-AE49-A0D1DEFE1452Q44570116-01FD5A67-B55B-4E02-B3A9-3E235B60EA29Q71198790-8C202DFB-55F4-4F03-A965-5FE64C5C0670Q90181906-E31E35D9-6010-47C2-8052-B895869E8950
P921
N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose
@en
type
label
N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose
@en
altLabel
(2>3')-a-Sialyllactose
@en
(2>3')-alpha-Sialyllactose
@en
(2S,4S,5R,6R)-2-{[(2R,3S,4S,5R ...... propyl]oxane-2-carboxylic acid
@en
3'-(N-Acetyl-a-neuraminosyl)lactose
@en
3'-(N-Acetyl-alpha-neuraminosyl)lactose
@en
3'-Monosialyllactose
@en
3'-N-Acetylneuraminyl-D-lactose
@en
3'-N-Acetylneuraminyl-delta-lactose
@en
3'-Sialyl-D-lactose
@en
3'-Sialyl-delta-lactose
@en
prefLabel
N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose
@en
P661
P662
P683
P1579
P2017
CC(=O)N[C@@H]1[C@H](C[C@@](O[C ...... ]([C@@H]([C@H]3O)O)O)CO)CO)O)O
P2067
633.211628
P231
35890-38-1
P233
CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OC2C(C(OC(C2O)OC3C(OC(C(C3O)O)O)CO)CO)O)O
P234
1S/C23H39NO19/c1-6(28)24-11-7( ...... ,17+,18+,19-,20+,21-,23-/m0/s1
P235
CILYIEBUXJIHCO-UITFWXMXSA-N
P274
C₂₃H₃₉NO₁₉